Article
Full-gene sequencing analysis of NAT2 and its relationship with isoniazid pharmacokinetics in Venezuelan children with tuberculosis.
Pharmacogenomics - 1 Feb 2014
Verhagen Lilly M, Coenen Marieke Jh, López Diana, García Juan F, de Waard Jacobus H, Schijvenaars Mascha M V A P, Hermans Peter W M, Aarnoutse Rob E
Abstract excerpt
BACKGROUND: Genetic variants in NAT2 are associated with pharmacokinetic variation of isoniazid, the cornerstone of antituberculosis treatment. We investigated the acetylator genotype and phenotype in children on antituberculosis treatment that were previously shown to have low plasma isoniazid l...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
